The cost-effectiveness of personalized genetic medicine: the case of genetic testing in neonatal diabetes.
about
Neonatal diabetes: an expanding list of genes allows for improved diagnosis and treatmentGenetics and pathophysiology of neonatal diabetes mellitus.Precision diabetes: learning from monogenic diabetes.Clinical and functional characterization of the Pro1198Leu ABCC8 gene mutation associated with permanent neonatal diabetes mellitusNeonatal Diabetes: Case Report of a 9-Week-Old Presenting Diabetic Ketoacidosis Due to an Activating ABCC8 Gene Mutation.Sulfonylurea treatment before genetic testing in neonatal diabetes: pros and consGenetic Testing and Type 2 Diabetes Risk Awareness.What Is the Best NGS Enrichment Method for the Molecular Diagnosis of Monogenic Diabetes and Obesity?Economic Evaluations of Pharmacogenetic and Pharmacogenomic Screening Tests: A Systematic Review. Second Update of the Literature.Age at the time of sulfonylurea initiation influences treatment outcomes in KCNJ11-related neonatal diabetesPhenotypic heterogeneity in monogenic diabetes: the clinical and diagnostic utility of a gene panel-based next-generation sequencing approachImplementing personalized medicine with asymmetric information on prevalence rates.Diabetes mellitus in neonates and infants: genetic heterogeneity, clinical approach to diagnosis, and therapeutic options.Monogenic diabetes: a diagnostic algorithm for cliniciansManagement of diabetes mellitus in infants.A systematic review and checklist presenting the main challenges for health economic modeling in personalized medicine: towards implementing patient-level models.Personalized management of hyperglycemia in type 2 diabetes: reflections from a Diabetes Care Editors' Expert Forum.Changing the Treatment of Permanent Neonatal Diabetes Mellitus from Insulin to Glibenclamide in a 4-Month-Old Infant with KCNJ11 Activating Mutation.Response letter to the editor.Congenital forms of diabetes: the beta-cell and beyond.Neonatal Diabetes Mellitus: An Update on Diagnosis and Management.Identification of insulin gene variants in neonatal diabetes.The diagnosis and management of monogenic diabetes in children and adolescents
P2860
Q27013756-96FFBC71-FC8D-4114-AC3E-81481F02BD20Q27865274-5EDD3826-CBD1-4F98-9DDD-B0579617A931Q33453490-161E056B-28C7-4AD7-A574-983F0A7A4DD2Q33588879-72116E45-8C5F-4F98-A89F-87BCF3C235A4Q33693263-00460272-DC40-42A5-9ACE-6E221040897EQ34628384-B9991771-C7F4-4DD0-82B5-D7816ACA2C14Q35761568-6EFA5AF2-826E-48A1-8D98-751DAA88476BQ35850123-41D9D4D0-ECA4-40E9-9DA2-D61231D750D7Q35890606-A0A00595-3217-4A79-9238-4235E2372658Q36270927-39237DDB-EDA8-43C9-A89D-9AA050E221E7Q36588444-2FDDAE4D-B934-49B7-B459-F40E6A5B2204Q37188012-6C75BEB3-5FBF-48D6-A15F-22D5A7A27D95Q37446924-B9736348-65FA-4A0C-8BCC-EFEAAAF481FDQ37590415-C1DE014A-A053-45B1-AB3C-DB03782579A8Q37962351-BE72C644-DB80-4C58-810B-7F470A4F357CQ39039319-4EBDF327-FEF5-40DE-B990-A1EA07EF132DQ39413300-65797E93-56B1-43A3-B051-06CA5A5AE50FQ41883942-84790A96-0415-4F25-B4CF-ED2849BAAAC2Q42360519-6DB97802-2549-4245-854E-7C2099D02490Q49901335-0902E275-16D9-479B-A7FD-268612ECBD5EQ50186120-AD113C1A-0B4B-41E4-A21C-C47818584BB0Q51712601-F9C0741F-47A5-4DD8-A95D-0CC486DC8F5FQ57303417-B6EDCBFD-B309-4C2C-9FFD-199B0973F48D
P2860
The cost-effectiveness of personalized genetic medicine: the case of genetic testing in neonatal diabetes.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The cost-effectiveness of pers ...... testing in neonatal diabetes.
@ast
The cost-effectiveness of pers ...... testing in neonatal diabetes.
@en
The cost-effectiveness of pers ...... testing in neonatal diabetes.
@nl
type
label
The cost-effectiveness of pers ...... testing in neonatal diabetes.
@ast
The cost-effectiveness of pers ...... testing in neonatal diabetes.
@en
The cost-effectiveness of pers ...... testing in neonatal diabetes.
@nl
prefLabel
The cost-effectiveness of pers ...... testing in neonatal diabetes.
@ast
The cost-effectiveness of pers ...... testing in neonatal diabetes.
@en
The cost-effectiveness of pers ...... testing in neonatal diabetes.
@nl
P2093
P2860
P356
P1433
P1476
The cost-effectiveness of pers ...... testing in neonatal diabetes.
@en
P2093
Aaron N Winn
Elbert S Huang
Graeme I Bell
Joseph Ornelas
Louis H Philipson
Priya M John
Rebecca B Lipton
Siri Atma W Greeley
P2860
P304
P356
10.2337/DC10-1616
P407
P577
2011-01-27T00:00:00Z